[1] JENKINS C,RAMÍREZ-ARCOS S,GOLDMAN M,et al. Bacterial contamination in platelets:incremental improvements drive down but do not eliminate risk[J]. Transfusion,2011,51(12):2555-2565. [2] BRECHER M E,JACOBS M R,KATZ L M,et al.Survey of methods used to detect bacterial contamination of platelet products in the United States in 2011[J]. Transfusion,2013,53(4):911-918. [3] WALKER B S,SCHMIDT R L,FISHER M A,et al.The comparative safety of bacterial risk control strategies for platelet components:a simulation study[J]. Transfusion,2020,60(8):1723-1731. [4] WHITE S K,SCHMIDT R L,WALKER B S,et al.Bacterial contamination rate of platelet components by primary culture:a systematic review and meta-analysis[J]. Transfusion,2020,60(5):986-996. [5] BENJAMIN R J,MCDONALD C P,ISBT TRANSFUSION TRANSMITTED INFECTIOUS DISEASE BACTERIAL WORKGROUP. The international experience of bacterial screen testing of platelet components with an automated microbial detection system:a need for consensus testing and reporting guidelines[J]. Transfus Med Rev,2014,28(2):61-71. [6] VASSALLO R,KAMEL H,GOEL R,et al.International forum on management of blood donors with culture-positive platelet donations:responses[J]. Vox Sang, 2023,118(11):1004-1023. [7] WAGNER S J,SNYDER E L.Identification and management of bacterially contaminated platelets-Back to the future[J]. Transfusion,2022,62(10):1948-1960. [8] MCDONALD C,ALLEN J,BRAILSFORD S,et al.Bacterial screening of platelet components by National Health Service Blood and Transplant,an effective risk reduction measure[J]. Transfusion,2017,57(5):1122-1131. [9] 徐蓓,杨剑豪,邱颖婕,等. 2016—2018年上海地区单采血小板制品细菌污染检测结果分析与展望[J]. 中国输血杂志,2018,31(9):989-993. [10] 马敏,王迅. 血小板制品细菌污染检测方法的研究进展[J]. 中国输血杂志,2007,20(4):348-351. [11] KAMEL H,RAMIREZ-ARCOS S,MCDONALD C,et al.The international experience of bacterial screen testing of platelet components with automated microbial detection systems:an update[J]. Vox Sang,2022,117(5):647-655. [12] SO B K,CHU C C,HO P L,et al.Evaluation of two chlorhexidine-alcohol-based skin disinfectants in blood donation setting[J]. Vox Sang,2014,106(4):316-321. [13] DE KORTE D,MARCELIS J H,VERHOEVEN A J,et al.Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections[J]. Vox Sang,2002,83(1):13-16. [14] BLOCH E M,MARSHALL C E,BOYD J S,et al.Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions[J]. Transfusion,2018,58(7):1647-1653. [15] United States Government.Food & Drug Administration(FDA). Bacterial risk control strategies for blood collectionestablishments and transfusion services to enhance the safetyand availability of platelets for transfusion; guidance for industry[EB/OL].[2024-08-07].extension://bfdogplmndidlpjfhoijckpakkdjkkil/pdf/viewer.html?file=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F123448%2Fdownload. [16] RIOS J,WEBB J,DY B,et al.The operational and financial impact of adding anaerobic screening of platelets[J]. Transfusion,2024,64(1):104-115. [17] KACKER S,KATZ L M,NESS P M,et al.Financial analysis of large-volume delayed sampling to reduce bacterial contamination of platelets[J]. Transfusion,2020,60(5):997-1002. [18] 徐蓓,孙静华,杨剑豪,等. 采供血机构血液成分制备质量监测指标的构建和初步评价[J]. 中国输血杂志,2020,33(9):986-989. |